Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Stephens

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Cell Reports. Medicine|July 12, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Cell Reports. Medicine|August 25, 2020
Rapid Generation of Neutralizing Antibody Responses in COVID-19 PatientsMehul S Suthar, Matthew G Zimmerman, Robert C Kauffman, et al.
Emerging Infectious Diseases|October 25, 2002
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigenConrad P Quinn, Vera A Semenova, Cheryl M Elie, et al.
The Journal of Infectious Diseases|April 29, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 VaccineRobert L Atmar, Kirsten E Lyke, Christine M Posavad, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary ReportRobert L Atmar, Kirsten E Lyke, Meagan E Deming, et al.
The New England Journal of Medicine|January 26, 2022
Homologous and Heterologous Covid-19 Booster VaccinationsRobert L Atmar, Kirsten E Lyke, Meagan E Deming, et al.
Cell Reports. Medicine|July 7, 2022
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variantKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
NPJ Vaccines|July 11, 2023
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variantsKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Cell Reports. Medicine|July 12, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Cell Reports. Medicine|August 25, 2020
Rapid Generation of Neutralizing Antibody Responses in COVID-19 PatientsMehul S Suthar, Matthew G Zimmerman, Robert C Kauffman, et al.
Emerging Infectious Diseases|October 25, 2002
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigenConrad P Quinn, Vera A Semenova, Cheryl M Elie, et al.
The Journal of Infectious Diseases|April 29, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 VaccineRobert L Atmar, Kirsten E Lyke, Christine M Posavad, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary ReportRobert L Atmar, Kirsten E Lyke, Meagan E Deming, et al.
The New England Journal of Medicine|January 26, 2022
Homologous and Heterologous Covid-19 Booster VaccinationsRobert L Atmar, Kirsten E Lyke, Meagan E Deming, et al.
Cell Reports. Medicine|July 7, 2022
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variantKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
NPJ Vaccines|July 11, 2023
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variantsKirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Pageof 15